Communication App for Post-Operative Pain Control
Trial Summary
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. However, since the trial involves patients with active opioid prescriptions, it seems likely that you can continue taking your prescribed opioids.
What data supports the effectiveness of the treatment OPY, Epic-Care Companion for post-operative pain control?
Is the Communication App for Post-Operative Pain Control safe for use in humans?
The studies reviewed focus on the use of smartphone apps for managing postoperative pain, particularly in children, and suggest that these apps can be used safely to report pain and improve pain management. However, specific safety data for the Communication App for Post-Operative Pain Control itself is not provided.26789
How is the Communication App for Post-Operative Pain Control treatment different from other treatments for post-operative pain?
The Communication App for Post-Operative Pain Control is unique because it uses an automated mobile phone messaging platform to communicate with patients after surgery, allowing for remote monitoring and management of pain without direct human intervention. This approach differs from traditional methods by providing continuous, real-time feedback and support, potentially reducing the need for opioids and improving patient outcomes.1461011
What is the purpose of this trial?
Digital communication tools are becoming ubiquitous in healthcare, though their impact on patient/provider communication, healthcare utilization, and outcomes remains poorly established. M Health Fairview (MHFV) in collaboration with the Center for Learning Health System Sciences (CLHSS) Rapid Eval team will be evaluating one such communication application: OPY, which leverages the Epic-Care Companion functionality to remove barriers in communicating with the patient's care team. This project will evaluate the effectiveness of a digital, post-operative patient engagement tool (Epic-Care Companion made available through MyChart), OPY, which has the goal of preventing patients from becoming addicted to opioids or to suffer from opioid misuse or diversion. In the proposed pragmatic trial, standard care with education available in MyChart and the patient after visit summary will be augmented by OPY. OPY is available to patients starting the same day they go home from surgery with a new opioid prescription. OPY provides a daily interactive experience that collects patient pain and side-effect information, provides advice for pain management, and uses behavioral "nudges" to encourage timely weaning and responsible disposal of opioid medications. The primary goal of this project is to evaluate the effect of two versions of OPY on measures of opiate use relative to the standard of care in a pragmatic randomized controlled trial.
Research Team
Genevieve Melton-Meaux, PhD
Principal Investigator
University of Minnesota
Eligibility Criteria
This trial is for patients who have had outpatient surgery at M Health Fairview Clinics in Maple Grove or Minneapolis, with a new opioid prescription. They must never have used the OPY app before and should be classified as outpatients or same-day surgery patients.Inclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Post-operative Engagement
Participants use the OPY app starting the same day they go home from surgery with a new opioid prescription. The app provides a daily interactive experience to collect pain and side-effect information, provide advice for pain management, and encourage responsible opioid use.
Follow-up
Participants are monitored for opiate use and patient-initiated outreach events through the care companion app.
Treatment Details
Interventions
- OPY
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Minnesota
Lead Sponsor